Skip to content
OpenCapital
Get started

BioAmber BIOA Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$2.1MBeat by $914.0KDiluted EPS-$0.56Beat by $0.11
Revenue estimate$1.1M
EPS estimate-$0.67

Next report

Aug 5, 2026 (In 3 weeks)
Revenue estimate$1.5M
EPS estimate-$0.65

Versus estimates

Revenue

Q1 2026$2.8MBeat by $1.7MQ4 2025$3.1MBeat by $1.7M
Q3 2025$2.1MBeat by $914.0K
Q2 2025$2.4MBeat by $1.5MQ1 2025$1.5MBeat by $871.0K

Diluted EPS

Q1 2026-$0.52Beat by $0.12Q4 2025-$0.72Beat by $0.11
Q3 2025-$0.56Beat by $0.11
Q2 2025-$0.60Miss by $0.04Q1 2025-$0.36Beat by $0.16Q4 2024-$1.97Miss by $1.39

Ask the moment BioAmber reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did BioAmber report Q3 2025 earnings?
BioAmber (BIOA) reported Q3 2025 earnings on November 6, 2025 before market open.
What were BioAmber's Q3 2025 revenue and EPS?
BioAmber reported revenue of $2.1M and diluted EPS of $-0.56 for Q3 2025.
Did BioAmber beat estimates in Q3 2025?
Revenue beat the consensus estimate of $1.1M by $914.0K. EPS beat the consensus estimate of $-0.67 by $0.11.
How did BioAmber's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 91.6% from $-6.70.
Where can I find BioAmber's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-269986) and the 10-Q periodic report (0001193125-25-270012) directly on SEC EDGAR. The filing index links above go to sec.gov.